Considering that genomic alterations such as mutation, deletion or amplification of the PTEN gene are not frequently observed in liver cancer [22], and liver cancer is one of the most prevalent life-threatening diseases in China [23], this cancer was chosen to study the function of PTENα/β. The gene discussed is PTEN; the disease is liver cancer.